CGNSF (Cognetivity Neurosciences) 3-1 Month Momentum %: N/A% (As of Sep. 10, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Cognetivity Neurosciences 3-1 Month Momentum %?

Cognetivity Neurosciences CGNSF -99.00% 3-1 Month Momentum % is N/A% as of Sep. 10, 2026.

3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-09-10), Cognetivity Neurosciences's 3-1 Month Momentum % is N/A%.

The industry rank for Cognetivity Neurosciences's 3-1 Month Momentum % or its related term are showing as below:

CGNSF's 3-1 Month Momentum % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.76
* Ranked among companies with meaningful 3-1 Month Momentum % only.

Cognetivity Neurosciences  (OTCPK:CGNSF) 3-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

Cognetivity Neurosciences 3-1 Month Momentum % Related Terms

CGNSF vs VEEV, GEHC, HQY: 3-1 Month Momentum % Comparison

For the Health Information Services subindustry, Cognetivity Neurosciences's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cognetivity Neurosciences 3-1 Month Momentum % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cognetivity Neurosciences's 3-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Cognetivity Neurosciences's 3-1 Month Momentum % falls into.


Cognetivity Neurosciences  (OTCPK:CGNSF) 3-1 Month Momentum % Calculation

3-1 Month Momentum % is calculated as following:

3-1 Month Momentum %=( Price 1-month ago / Price 3-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 3-1 Month Momentum % →
What does a 3-1 Month Momentum % of N/A% mean?
Cognetivity Neurosciences (CGNSF) has a 3-1 Month Momentum % of N/A% as of Sep. 10, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Cognetivity Neurosciences and its competitors.
Is Cognetivity Neurosciences' 3-1 Month Momentum % too high?
Cognetivity Neurosciences' current 3-1 Month Momentum % is N/A%.
How does Cognetivity Neurosciences' 3-1 Month Momentum % compare to VEEV and GEHC?
Cognetivity Neurosciences' 3-1 Month Momentum % of N/A% can be compared against companies in the Healthcare Providers & Services industry. The industry median 3-1 Month Momentum % is 1.76. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Healthcare Providers & Services company?
The median 3-1 Month Momentum % among Healthcare Providers & Services companies is 1.76, based on 663 companies in the industry. Companies in the top quartile (top 25%) have a 3-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Cognetivity Neurosciences and its competitors. For the Healthcare Providers & Services industry, the median 3-1 Month Momentum % is 1.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cognetivity Neurosciences's current 3-1 Month Momentum % is N/A%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cognetivity Neurosciences stock overvalued right now?
Cognetivity Neurosciences (CGNSF) has a current 3-1 Month Momentum % of N/A%. The current 3-1 Month Momentum % is N/A%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Cognetivity Neurosciences (CGNSF), the current 3-1 Month Momentum % is N/A% as of Sep. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cognetivity Neurosciences Business Description

Address 800 West Pender Street, Suite 1430, Vancouver, BC, CAN, V6C 2V6
Cognetivity Neurosciences Ltd is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial, and consumer environments for potentially allowing early diagnosis of dementia. The Company is considered operating in one segment for development of the ICA platform. Its geographical areas include Canada, United Kingdom and Dubai.